Clinical Trials

Showing 141 - 160 of 485 trials
Titlesort icon Investigator Disease(s)
A Phase IA/B Study of CC-115 in Castration-Resistant Prostate Cancer
[Protocol 12-080]
Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase Ib Study of AEB071 and MEK162 in Patients with Advanced Uveal Melanoma
[Protocol 13-172]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase Ib Study of ARN-509 plus Everolimus in Men with Progressive Metastatic Castration-Resistant Prostate Cancer After Abiraterone Therapy
[Protocol 13-025]
Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase IB Study of LEE011 and Exemestane with and without Everolimus in Women with Locally Advanced or Metastatic Breast Cancer
[Protocol 13-179]
Modi, Shanu
  • Breast Cancer
A Phase Ib Study of MDX-1106 (BMS-936558) in Combination with Ipilimumab (BMS-734016) in Patients with Unresectable Stage III or Stage IV Malignant Melanoma
[Protocol 09-155]
Wolchok, Jedd
  • Melanoma
A Phase IB Study of MEK162 plus Paclitaxel in Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-192]
Grisham, Rachel
  • Ovarian Cancer
A Phase IB Study of MK-3475 in Patients with Myelodysplastic Syndromes and Lymphoma
Relapsed/Refractory
[Protocol 13-220]
Moskowitz, Craig
  • Hematology
    • Myelodysplastic Syndrome
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase IB Study of MPDL3280A and Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 14-020]
Rudin, Charles
A Phase IB Study of MPDL3280A plus Cobimetinib in Patients with Locally Advanced or Metastatic Solid Tumors
[Protocol 13-223]
Rizvi, Naiyer
  • Solid Tumors
A Phase Ib Study of OMP-54F28 with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
[Protocol 14-029]
O'Cearbhaill, Roisin
  • Ovarian Cancer
A Phase IB Study of Onartuzumab Given with Sorafenib in Patients with Advanced Liver Cancer
[Protocol 13-155]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase Ib Study of Oral BGJ398 and BYL719 in Patients with Certain Advanced Solid Tumors
[Protocol 13-246]
Fury, Matthew
  • Breast Cancer
  • Solid Tumors
A Phase IB Study of REGN910 and Aflibercept plus Paclitaxel in Women with Recurrent Ovarian Cancer
[Protocol 13-156]
Konner, Jason
  • Ovarian Cancer
A Phase IB Study of SAR650984 with Lenalidomide and Dexamethasone to Treat Recurrent or Persistent Multiple Myeloma
[Protocol 13-006]
Lendvai, Nikoletta
  • Hematology
    • Multiple Myeloma
A Phase Ib Study of Tremelimumab and MEDI4736 in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 13-197]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
A Phase Ib Study of Urelumab Given with Rituximab in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
Relapsed/Refractory
[Protocol 13-252]
Zelenetz, Andrew
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase Ib/II Study of AEB071 and Everolimus in Patients with CD79-Mutant or ABC Diffuse Large B-Cell Lymphoma
[Protocol 13-225]
Gerecitano, John
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase Ib/II Study of Gemcitabine and Docetaxel Plus Pazopanib for the Neoadjuvant (Presurgical) Treatment of Soft-Tissue Sarcoma
[Protocol 11-104]
Tap, William
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase Ib/II Study of LGX818 and Cetuximab with or without BYL719 in Patients with BRAF-Mutant Metastatic Colorectal Cancer
[Protocol 14-019]
Yaeger, Rona
  • Colorectal Cancer